Improved HPLC method for determination of four PPis, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 1, 2010, Pages 1-10

  Noubarani, Maryam ^a   Keyhanfar, Fariborz ^a   Motevalian, Manijeh ^a   Mahmoudian, Masoud ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; FASTAB; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PHOSPHATE BUFFERED SALINE; PROTON PUMP INHIBITOR; RABEKIND FAST; RABEPRAZOLE; TRIETHYLAMINE; UNCLASSIFIED DRUG; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLOW RATE; HUMAN; LIQUID LIQUID EXTRACTION; PH; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; ADULT; BLOOD; CLINICAL TRIAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; VALIDATION STUDY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 77955493430     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3gp4q     Document Type: Article

References (31)

1. Sachs G, Shin JM, Howden CW. Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther, 2006; 23:2-8.
2. Gardiner SJ, Begg EJ. Pharmacogenetics, drugmetabolizing enzymes, and clinical practice. Pharmacol Rev, 2006; 58:521-90.
3. Amantea MA, Narang PK. Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography. J Chromatogr, 1988; 426:216-22.
4. Garcia-Encina G, Farran R, Puig S, Martinez L. Validation of an automated liquid chromatographic method for omeprazole in human plasma using online solid-phase extraction. J Pharm Biomed Anal, 1999; 21:371-82.
5. Gonzalez HM, Romero EM, Chavez TdeJ, Peregrina AA, Quezada V, Hoyo-Vadillo C. Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction. J Chromatogr B Analyt Technol Biomed Life Sci, 2002; 780:459-465.
6. Kobayashi K, Chiba K, Sohn DR, Kato Y, Ishizaki T. Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversedphase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. J Chromatogr, 1992; 579:299-305.
7. Lagerstrom PO, Persson BA. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. J Chromatogr, 1984; 309:347-56.
8. Macek J, Ptacek P, Klima J. Determination of omeprazole in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 1997; 689:239-43.
9. Mihaly GW, Prichard PJ, Smallwood RA, Yeomans ND, Louis WJ. Simultaneous highperformance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urine. J Chromatogr, 1983; 278:311-9.
10. Motevalian M, Saeedi G, Keyhanfar F, Tayebi L, Mahmoudian M. Simultaneous determination of omeprazole and its metabolites in human plasma by HPLC using solid-phase extraction. pharm pharmacol comun, 1999; 5:265-268.
11. Prasad NV T, Steven L B. High Performance Liquid Chromatographic Method for the Analysis of Omeprazole and 5-Hydroxyomeprazole in Human Plasma. Analytical Letters, 1999; 32:2285-2295.
12. Rambla-Alegre M, Esteve-Romero J, Carda-Broch S. Analysis of omeprazole and its main metabolites by liquid chromatography using hybrid micellar mobile phases. Anal Chim Acta, 2009; 633:250-6.
13. Rezk NL, Brown KC, Kashuba AD. A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RPHPLC after a simple liquid-liquid extraction procedure. J Chromatogr B Analyt Technol Biomed Life Sci, 2006; 844:314-21.
14. Shimizu M, Uno T, Niioka T, Yaui-Furukori N, Takahata T, Sugawara K, Tateishi T. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes. J Chromatogr B Analyt Technol Biomed Life Sci, 2006; 832:241-8.
15. Yim DS, Jeong JE, Park JY. Assay of omeprazole and omeprazole sulfone by semi-microcolumn liquid chromatography with mixed-function precolumn. J Chromatogr B Biomed Sci Appl, 2001; 754:487-93.
16. Yuen KH, Choy WP, Tan HY, Wong JW, Yap SP. Improved high performance liquid chromatographic analysis of omeprazole in human plasma. J Pharm Biomed Anal, 2001; 24:715-9.
17. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. HPLC determination of omeprazole in human plasma using a monolithic column. Arzneimittelforschung, 2006; 56:382-6.
18. Kang WK, Kim DS, Kwon KI. Advanced method for determination of omeprazole in plasma by HPLC. Arch Pharm Res, 1999; 22:86-8.
19. Aoki I, Okumura M, Yashiki T. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. J Chromatogr, 1991; 571:283-90.
20. Huber R, Muller W, Banks MC, Rogers SJ, Norwood PC, Doyle E. High-performance liquid chromatographic determination of the H+/K+ ATPase inhibitor (BY 1023/SK&F 96,022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up. J Chromatogr, 1990; 529:389-401.
21. Karol MD, Granneman GR, Alexander K. Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl, 1995; 668:182-6.
22. Landes BD, Miscoria G, Flouvat B. Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography using a loop column. J Chromatogr, 1992; 577:117-22.
23. Ramakrishna NV, Vishwottam KN, Wishu S, Koteshwara M. High-performance liquid chromatography method for the quantification of pantoprazole in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 2005; 822:326-9.
24. Uno T, Yasui-Furukori N, Shimizu M, Sugawara K, Tateishi T. Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci, 2005; 824:238-43.
25. Zarghi A, Shafaati A, Foroutan SM, Movahed H, Khoddam A. A rapid high-performance liquid chromatographic method for the determination of pantoprazole in plasma using UV detection. Application in pharmacokinetic studies. Arzneimittelforschung, 2008; 58:441-4.
26. Park CW, Rhee YS, Go BW, Kam SH, Lee KH, Lee HS, Park ES. High performance liquid chromatographic analysis of rabeprazole in human plasma and its pharmacokinetic application. Arch Pharm Res, 2008; 31:1195-9.
27. Singh SS, Jain M, Shah H, Gupta S, Thakker P, Shah R, Lohray BB. Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci, 2004; 813:247-54.
28. Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T. Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching highperformance liquid chromatography: application to measuring CYP2C19 activity. J Chromatogr B Analyt Technol Biomed Life Sci, 2005; 816:309-14.
29. Hishinuma T, Suzuki K, Yamaguchi H, Yamagishi H, Koike T, Ohara S, Shimosegawa T, Mano N, Goto J. Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2008; 870:38-45.
30. Gupta HP, Saini K, Dhingra P, Pandey R. Study of Acid Catalyzed Reactions of Proton Pump Inhibitors at D.M.E. Portugaliae Electrochimica Acta, 2008; 26(5):433-448.
31. Shah VP, Midha KK, Findlay John WA, et al. Bioanalytical Method Validation-A Revisit with a Decade of Progress. Pharmaceutical Research, 2000; 17:1551-1557.